Institutional Career Development Core
Institutional Career Development Core
批准号:
10625360
负责人:
Sarah Jane Schlesinger
金额:
$91.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-07-05 至 2026-05-31
关键词:
AdherenceBioinformaticsBiometryCareer ChoiceClinicalClinical ResearchClinical SciencesCompetenceComplementConceptionsDegree programEducationElectronic Health RecordEpidemiologyFeedbackFormulationGoalsGrantHealthHealth ProfessionalHealth StatusHumanHumanitiesInstitutionInstructionLeadLeadershipMaster of ScienceMentorsMethodsModelingOntologyParticipantPharmacologic SubstancePhenotypePhysiciansPoliciesPrivatizationProductionProtocols documentationReportingReproducibilityResearchResourcesScienceScientistSpecial EventTrainingTranslational ResearchTranslationsUnited States National Academy of SciencesUniversitiesVisioncareercareer developmentclinical centercommunity engagementdidactic educationempowermentexperienceimprovedinnovationmeetingsmembernew technologyprogramsresponsible research conducttranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall vision of the Rockefeller University Center for Clinical and Translational Science (CCTS), supported
by the CTSA program, is to develop, demonstrate, and disseminate innovative programs so as to create a model
clinical research enterprise built on rigor, responsible and transparent reporting, and scientific integrity to
empower translation of paradigm-breaking discoveries into better human health. The overarching goal of our
KL2 Clinical Scholars Master's degree program is to prepare our trainees to be successful, scientifically
independent, translational investigators who can lead translational teams on projects to improve human health.
The core of the program is a mentored translational research experience in which the Scholar serves as a
translational team science leader, and develops, conducts, analyzes, and disseminates the results of a human
participant study under the guidance of a distinguished senior scientific mentor and with the assistance of a
cadre of Translational Science Team Experts/Educators. This experience is complemented by a didactic
curriculum including tutorials in Clinical and Translational Science, Biostatistics, Bioinformatics, and
Epidemiology; a weekly Clinical Research Seminar by outstanding translational investigators; a private weekly
meeting with the seminar speaker; team science leadership training; a graduate level scientific course;
Humanities and Translational Science special events; and training in the Responsible Conduct of Research. Our
program benefits from the scientific strength of the mentors in the program, with 10 of the mentors of Scholars
during the current grant period being elected members of the National Academy of Sciences. Thus, our specific
aims are: 1. To train physician scientists and doctoral level health professionals as outstanding, scientifically
independent translational investigators in a 3 year mentored KL2 Clinical Scholars Master's degree program that
includes: a) leadership of a human participant protocol from conception to reporting, b) a didactic curriculum to
help the Scholar master the competencies to function as a rigorous independent translational scientist, c)
focused instruction and feedback to develop the team science leadership competencies required to successfully
lead a translational science team. 2. To introduce new educational programs to maximize Scholars' educational
experience and ability to consider a wide variety of career choices, as well as benefit from emerging new
technology and resources: a) Team science leadership training, b) Pharmaceutical production and formulation,
d) Ontology-driven human phenotyping, e) Searching Electronics Health Records and causal inference, e) From
discovery to health-enhancing product, and f) Engaging communities as full partners. 3. Reinforce the
importance of achieving the highest possible levels of rigor, reproducibility, and reporting (R3) and assist
Scholars in developing best practices early in their research careers so that they can incorporate new methods
and policies to constantly improve their adherence to evolving standards.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.4049/jimmunol.1800013
发表时间:
2018-09-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Hawkes JE, Yan BY, Chan TC, Krueger JG]
通讯作者:
Krueger JG
DOI:
10.1111/exd.13378
发表时间:
2017-11
期刊:
Experimental dermatology
影响因子:
3.6
作者:
[Fuentes-Duculan J, Bonifacio KM, Hawkes JE, Kunjravia N, Cueto I, Li X, Gonzalez J, Garcet S, Krueger JG]
通讯作者:
Krueger JG
DOI:
10.1016/j.jaci.2017.07.004
发表时间:
2017-09
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Hawkes JE, Chan TC, Krueger JG]
通讯作者:
Krueger JG
DOI:
10.1017/cts.2017.308
发表时间:
2017-10
期刊:
Journal of clinical and translational science
影响因子:
2.6
作者:
[Schlesinger SJ, Romanick M, Tobin JN, Brassil D, Kost RG, Devine R, O'Sullivan B, Vaughan RD, Liang Y, da Rosa JC, Williams M, Krueger JG, Coller BS]
通讯作者:
Coller BS
Institutional Career Development Core
-
批准号:10413257
-
项目类别:
-
资助金额:$60.9万
-
财政年份:2016
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Institutional Career Development Core
-
批准号:10349634
-
项目类别:
-
资助金额:$89.6万
-
财政年份:2016
-
负责人:Sarah Jane Schlesinger
-
依托单位:
A New Anti-CD27 Monoclonal Antibody Adjuvant for Pancreatic Cancer Vaccines
-
批准号:8416332
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2012
-
负责人:Sarah Jane Schlesinger
-
依托单位:
A New Anti-CD27 Monoclonal Antibody Adjuvant for Pancreatic Cancer Vaccines
-
批准号:8273920
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2012
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Identification and vaccine adjuvant responses of dendritic cells in humans
-
批准号:8292381
-
项目类别:
-
资助金额:$51.99万
-
财政年份:1996
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Clinical Immunology Services Core
-
批准号:9631984
-
项目类别:
-
资助金额:$23.07万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Pilot Core
-
批准号:9233908
-
项目类别:
-
资助金额:$26.05万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Clinical Immunology Services Core
-
批准号:9233907
-
项目类别:
-
资助金额:$21.98万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Pilot Core
-
批准号:8827244
-
项目类别:
-
资助金额:$28.78万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Clinical Immunology Services Core
-
批准号:8726169
-
项目类别:
-
资助金额:$27.19万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Pilot Core
-
批准号:8726170
-
项目类别:
-
资助金额:$28.78万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
Clinical Immunology Services Core
-
批准号:9035358
-
项目类别:
-
资助金额:$24.28万
-
财政年份:--
-
负责人:Sarah Jane Schlesinger
-
依托单位:
海外基金